Applying the syndemic framework to cancer research for effective cancer control in LMICs

Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes transactivation-independent mitochondrial cell death

Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC

The multidisciplinary team (MDT) approach and quality of care

Breast and emerging indications for IORT

The advantages of IORT for early breast cancer treatment

CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC

Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours

Does the mind matter in cancer? Experiences of Psycho-oncology from a tertiary cancer centre in South Asia

Challenge mission to improve access to quality cancer care

Choosing Wisely: An important step in the right direction

Cancer situation in Cambodia